Zynerba Pharmaceuticals Inc reports results for the quarter ended in September - Earnings Summary

Zynerba Pharmaceuticals

15/11/2021 14:15

* Zynerba Pharmaceuticals Inc  ZYNE.OQ  reported a quarterly
adjusted loss of 26 cents​​ per share for the quarter ended in
September. The mean expectation of seven analysts for the
quarter was for a loss of 25 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Zynerba Pharmaceuticals Inc's reported EPS for the quarter was
a loss of 26 cents​.
* The mean earnings estimate of analysts had risen by about 0.5%
in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Zynerba Pharmaceuticals Inc shares had risen by 0.9% this
quarter and gained 29.7% so far this year.
* The company reported a quarterly loss of $10.58 million.
* Wall Street's median 12-month price target for Zynerba
Pharmaceuticals Inc is $8.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 5 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
This summary was machine generated November 15 at 02:14 p.m.
 ​All figures in US dollars unless otherwise stated